Testing: Tissue Testing

When a biopsy is taken from a tumor, the tissue must be analyzed for cell abnormalities to determine if it is cancerous and malignant. Analysis also reveals the type of cancer the patient has.

The first type of test uses a process called flow cytometry. Flow cytometry is done in a high-tech machine. The process sorts through the cells from the biopsy and examines them for certain cell markers that are found in the membranes of cells. These markers, called clusters of differentiation (CD), identify certain types of cancer cells.

The second test examines the DNA of biopsied cells. Laboratory technicians examine DNA for genetic abnormalities. These abnormalities cause the mutations in cancerous cells, which causes them to grow faster than normal, healthy cells, thus creating a tumor. Identification of these abnormalities helps classify cancer.

Once the biopsied tissue is examined using both of these techniques, the doctor can identify the type of cancer a patient has and then perform the necessary tests to stage the disease.

These tests are also useful in determining the type of treatment to give a patient. Some cell markers bind with antibodies – "tags" that mark the cell for removal by the immune system – so immunotherapy can be used. For more information on this type of treatment, please see the article titled Monoclonal Antibody Therapy.

Dive Deeper

For more information on Hodgkin's disease, please see the following pages

For more information on Non-Hodgkin lymphoma, please see the following pages:

More Articles

More Articles

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...

While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a...

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Lymphoma is a life-threatening disease, but is very treatable in most cases. The 5-year survival for patients diagnosed with non-Hodgkin's...

T cell lymphoma treatment options for these cancers are not especially effective and there is no absolute consensus about optimal treatments for...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...